Pertussis

Medical Clinics of North America

Volumn 97, Issue 4, 2013, Pages 537-552

  Spector, Tara B ^a   Maziarz, Eileen K ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bordetella pertussis; Immunization; Pertussis; Whooping cough

Indexed keywords

ADENYLATE CYCLASE TOXIN; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; VIRULENCE FACTOR;

ALLERGIC REACTION; ALLERGIC RHINITIS; ARM PAIN; ARM SWELLING; ASTHMA; BACTERIAL PNEUMONIA; BACTERIAL SINUSITIS; BACTERIAL TRANSMISSION; BRAIN DAMAGE; BRAIN DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIATED EPITHELIUM; COMA; CONGESTIVE HEART FAILURE; CONJUNCTIVAL HEMORRHAGE; COUGHING; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FAINTNESS; FATIGUE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; HEADACHE; HERNIA; HOST RESISTANCE; HUMAN; IMMUNIZATION; INCONTINENCE; INCUBATION TIME; INFECTION RISK; INJECTION SITE PAIN; MORBIDITY; MORTALITY; NASOPHARYNGEAL ASPIRATION; NASOPHARYNX; NOSE SMEAR; PERTUSSIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RIB FRACTURE; SEIZURE; TISSUE INJURY; UPPER RESPIRATORY TRACT; VIRUS PNEUMONIA; WEIGHT REDUCTION;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PERTUSSIS VACCINE; RISK FACTORS; UNITED STATES; WHOOPING COUGH; WORLD HEALTH;

EID: 84879783209     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.02.004     Document Type: Review

References (61)

1. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18(2):326-382.
2. Cherry J.D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984, 14(2):1-78.
3. Centers for Disease Control and Prevention. Pertussis (whooping cough). Pertussis in other countries. Available at: Accessed November 27, 2012. http://www.cdc.gov/pertussis/countries.html.
4. Crowcroft N.S., Booy R., Harrison T., et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003, 88:802-806.
5. Centers for Disease Control and Prevention. Pertussis (whooping cough). Outbreaks. Available at: Accessed December 29, 2012. http://www.cdc.gov/pertussis/outbreaks.html.
6. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988, 296(6622):612-614.
7. Zouari A., Smaoui H., Kechrid A. The diagnosis of pertussis: which method to choose?. Crit Rev Microbiol 2012, 38(2):111-121.
8. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 2011, 60(1):13-15.
9. Finger H., Wirsing von Konig C.H. Bordetella. Medical microbiology 1996, University of Texas Medical Branch at Galveston, Galveston (TX), Available at:, Accessed on October 15, 2012. http://www.ncbi.nlm.nih.gov/books/NBK7813/, 4th edition. S. Baron (Ed.).
10. Deen J.L., Mink C.M., Cherry J.D., et al. Household contact study of Bordetella pertussis infection. Clin Infect Dis 1995, 21(5):1211-1219.
11. Mertsola J., Ruuskanen O.L., Eerola E., et al. Intrafamiliar spread of pertussis. JPediatr 1983, 103:359-363.
12. Wirsing von Konig C.H., Postels-Multani S., Bogaerts H., et al. Factors influencing the spread of pertussis in households. Eur J Pediatr 1998, 157:391-394.
13. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis 1984, 3:467-486.
14. Christie C.D., Baltimore R.S. Pertussis in neonates. Am J Dis Child 1989, 143:1199-1202.
15. Tan T., Trindade E., Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005, 24:S10-S18.
16. Centers for Disease Control and Prevention Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005, 54(50):1283-1286.
17. Guris D., Strevel P.M., Bardenheier B., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999, 28(6):1230-1237.
18. Wirsing von Konig C.H., Halperin S., Riffelmann M., et al. Pertussis of adults and infants. Lancet Infect Dis 2002, 2(12):744-750.
19. Halperin S.A., Wang E.E., Law B., et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999, 28:1238-1243.
20. Tanaka M., Vitek C.R., Pascual F.B., et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003, 290(22):2268-2275.
21. Vitek C.R., Pascual F.B., Baughman A.L., et al. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003, 22(7):628-634.
22. Centers for Disease Control and Prevention Pertussis outbreak in an Amish community-Kent County, Delaware, September 2004-February 2005. MMWR Morb Mortal Wkly Rep 2006, 55:817-821.
23. Craig A.S., Wright S.W., Edwards K.M., et al. Outbreak of pertussis on a college campus. Am J Med 2007, 120:364-368.
24. Waters V., Halperin S. Bordetella pertussis. Mandell, Douglas, and Bennett's: principles and practice of infectious diseases 2010, vol. 2:2955-2964. Elsevier, Philadelphia. 7th edition.
25. Levene I., Wacogne I. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants?. Arch Dis Child 2001, 96:1203-1205.
26. Pierce C., Klein N., Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection?. Intensive Care Med 2000, 26:1512-1514.
27. Cornia P.B., Hersch A.L., Lipsky B.A., et al. Does this coughing adolescent or adult patient have pertussis?. JAMA 2010, 304(8):890-896.
28. Strebel P., Nordin J., Edwards K., et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. JInvest Dermatol 2001, 183:1353-1359.
29. Kretsinger K., Broder R., Cortese M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 2006, 55(RR17):1-33.
30. Irwin R.S., Madison J.M. The diagnosis and treatment of cough. NEngl J Med 2000, 343(23):1715-1721.
31. World Health Organization-recommended surveillance standard of pertussis. Available at: Accessed October 10, 2012. http://www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/index.html.
32. Centers for Disease Control and Prevention Appendix B. CDC and Council of State and Territorial Epidemiologists (CTSE) pertussis case definition. MMWR Morb Mortal Wkly Rep 2006, 55(RR17):35. Available at:, Accessed October 31, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a3.htm.
33. Ghanie R.M., Karimi A., Sadeghi H., et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 2010, 14:e1072-e1075.
34. Cherry J.D., Tan T., Wirsing von Konig C.H., et al. Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis 2012, 54:1756-1765.
35. Marcon M.J., Hamoudi A.C., Cannon H.J., et al. Comparison of throat and nasopharyngeal swab specimens for culture diagnosis of Bordetella pertussis infection. JClin Microbiol 1987, 25(6):1109-1110.
36. Hallander H.O., Reizenstein E., Renemar B., et al. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. JClin Microbiol 1993, 31(1):50-52.
37. Cloud J.L., Hymas W., Caroll K.C. Impact of nasopharyngeal swab types of detection of Bordetella pertussis by PCR and culture. JClin Microbiol 2002, 40(10):3838-3840.
38. Muller F.M., Hoppe J.E., Wirsing von Konig C.H. Laboratory diagnosis of pertussis: state of the art in 1997. JClin Microbiol 1997, 35(10):2435-2443.
39. Young S.A., Anderson G.L., Mitchell P.D. Laboratory observations during an outbreak of pertussis. Clin Microbiol Newsl 1987, 9:176-179.
40. Centers for Disease Control and Prevention Outbreaks of respiratory illness mistakenly attributed to pertussis-New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb Mortal Wkly Rep 2007, 56(33):837-842.
41. Guiso N., Berbers G., Fry N.K., et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011, 30:307-312.
42. Tiwari T., Murphy T.V., Moran J. Recommended antimicrobial agents for the treatment and post-exposure prophylaxis of pertussis; 2005 CDC Guidelines. MMWR Morb Mortal Wkly Rep 2005, 54(RR-14):1-16.
43. Altunaiji S., Kukuruzovic R., Curtis N., et al. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007, (3). CD004404.
44. Aoyama T., Sunakawa K., Iwata S., et al. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. JPediatr 1996, 129(5):761-764.
45. Langley J.M., Halperin S.A., Boucher F.D., et al. Azithromycin is as effective as and better tolerated than erythromycin for the treatment of pertussis. Pediatrics 2004, 114(1):e96-e101.
46. Lebel M.H., Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. PediatrInfect Dis 2001, 20(12):1149-1154.
47. Maheshwai N. Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?. Arch Dis Child 2007, 92:271-273.
48. Hoppe J.E., Halm U., Hagedorn H.J. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 1989, 4:227-231.
49. Bettiol S., Wang K., Thompson M.J., et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2012, (5). CD003257.
50. Centers for Disease Control and Prevention FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular Pertussis Vaccine. MMWR Morb Mortal Wkly Rep 2011, 60(37):1279-1280.
51. Le T., Cherry J.D., Chang S.J., et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT study. JInfect Dis 2004, 190:535-544.
52. Ward J.L., Cherry J.D., Chang S.J., et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. NEngl J Med 2005, 353(15):1555-1563.
53. Centers for Disease Control and Prevention Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000, 49(RR-13):1-8.
54. Mertsola J., Van Der Meeren O., He Q., et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis 2010, 51(6):656-662.
55. Cherry J.D. The present and future control of pertussis. Clin Infect Dis 2010, 51(6):663-667.
56. Centers for Disease Control and Prevention. Possible side effects from vaccines. Available at: Accessed November 14, 2012. http://www.cdc.gov/vaccines/vac-gen/side-effects.htm#td.
57. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011, 60(41):1424-1426.
58. Committee on Obstetric Practice Committee Opinion: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol 2012, 119(3):690-691.
59. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(4):334.e1.
60. Shakib J.H., Ralson S., Raissy H.H., et al. Pertussis antibodies in postpartum women and their newborns. JPerinatol 2010, 30:93-97.
61. Calugar A., Ortega-Sánchez I.R., Tiwari T., et al. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006, 42(7):981-988.